Tibet Aim Pharm Inc (002826) - Cash Flow Conversion Efficiency

Latest as of September 2025: 0.109x

Based on the latest financial reports, Tibet Aim Pharm Inc (002826) has a cash flow conversion efficiency ratio of 0.109x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (CN¥87.55 Million ≈ $12.81 Million USD) by net assets (CN¥802.15 Million ≈ $117.38 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. See 002826 cash and liquid assets coverage to measure how many days the company can operate on defensive assets alone.

Tibet Aim Pharm Inc - Cash Flow Conversion Efficiency Trend (2013–2025)

This chart illustrates how Tibet Aim Pharm Inc's cash flow conversion efficiency has evolved over time, based on yearly financial data.

Tibet Aim Pharm Inc Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Tibet Aim Pharm Inc ranked by their cash flow conversion efficiency.

Company	Cash Flow Conversion Efficiency
North American Financial 15 TO:FFN	0.060x
WHA UTILITIES AND PO BK:WHAUP-R	0.024x
Hunan Resun Co Ltd SHE:001218	0.053x
Ooma Inc NYSE:OOMA	0.067x
The Star Entertainment Group Ltd AU:SGR	-0.170x
Wilson Bayly Holmes Ovcon Ltd JSE:WBO	0.150x
Sygnity SA WAR:SGN	0.145x
Shanghai SK Petroleum & Chemical Equipment Corp Ltd SHE:002278	-0.008x

Annual Cash Flow Conversion Efficiency for Tibet Aim Pharm Inc (2013–2025)

The table below shows the annual cash flow conversion efficiency of Tibet Aim Pharm Inc from 2013 to 2025. For the full company profile with market capitalisation and key ratios, see Tibet Aim Pharm Inc market capitalisation.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2025-12-31	CN¥816.02 Million ≈ $119.41 Million	CN¥123.72 Million ≈ $18.10 Million	0.152x	+1.31%
2024-12-31	CN¥745.58 Million ≈ $109.10 Million	CN¥111.57 Million ≈ $16.33 Million	0.150x	-32.74%
2023-12-31	CN¥750.06 Million ≈ $109.76 Million	CN¥166.88 Million ≈ $24.42 Million	0.222x	+143.77%
2022-12-31	CN¥750.00 Million ≈ $109.75 Million	CN¥68.45 Million ≈ $10.02 Million	0.091x	-39.99%
2021-12-31	CN¥720.11 Million ≈ $105.37 Million	CN¥109.52 Million ≈ $16.03 Million	0.152x	+2.73%
2020-12-31	CN¥687.15 Million ≈ $100.55 Million	CN¥101.74 Million ≈ $14.89 Million	0.148x	+63.10%
2019-12-31	CN¥652.17 Million ≈ $95.43 Million	CN¥59.20 Million ≈ $8.66 Million	0.091x	+321.64%
2018-12-31	CN¥618.40 Million ≈ $90.49 Million	CN¥13.31 Million ≈ $1.95 Million	0.022x	-83.16%
2017-12-31	CN¥604.53 Million ≈ $88.46 Million	CN¥77.29 Million ≈ $11.31 Million	0.128x	+24.19%
2016-12-31	CN¥555.44 Million ≈ $81.28 Million	CN¥57.18 Million ≈ $8.37 Million	0.103x	+186.07%
2015-12-31	CN¥248.25 Million ≈ $36.33 Million	CN¥-29.69 Million ≈ $-4.34 Million	-0.120x	-1080.84%
2014-12-31	CN¥179.12 Million ≈ $26.21 Million	CN¥2.18 Million ≈ $319.61K	0.012x	-98.33%
2013-12-31	CN¥71.66 Million ≈ $10.49 Million	CN¥52.24 Million ≈ $7.64 Million	0.729x	--

About Tibet Aim Pharm Inc

SHE:002826 China Drug Manufacturers - Specialty & Generic

Market Cap

$469.59 Million

CN¥3.21 Billion CNY

Market Cap Rank

#12732 Global

#3768 in China

Share Price

CN¥16.83

Change (1 day)

+1.94%

52-Week Range

CN¥15.01 - CN¥25.74

All Time High

CN¥32.76